ALETHEA CAPITAL MANAGEMENT, LLC

Position in RNA — Atrium Therapeutics, Inc.

CIK 1549408 MERCER ISLAND, WA

Position in RNA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$588,545

+$3,501 QoQ

Shares Held

43,758

0.0% QoQ

Ownership

0.256%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

#56

of 154 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ALETHEA CAPITAL MANAGEMENT, LLC holds $185,526,775 across 4 Biotechnology names. RNA ranks #4 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	648,756	$158,796,006
2	KURA	Kura Oncology, Inc.	2,167,938	$23,782,279
3	IMRX	Immuneering Corp	472,935	$2,359,945
4	RNA	Atrium Therapeutics, Inc. This page	43,758	$588,545

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$588,545	43,758	0.0%	Shares	Sole	2026-08-14
2026-03-31	$585,044	43,758	—	Shares	Sole	2026-05-13
No filing history on record for this holder in this stock.